Affiliated Cancer Hospital of Harbin Medical University — Harbin, Heilongjiang

Public research footprint of Affiliated Cancer Hospital of Harbin Medical University, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer · Breast Cancer · Advanced Hepatocellular Carcinoma · Small Cell Lung Cancer (SCLC)

Recently updated registry entries

NCT05770310 — A Phase I Study Of JS015 in Patients With Advanced Solid Tumors (Completed)
NCT07385703 — Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab… (Recruiting)
NCT06443684 — A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Affiliated Cancer Hospital of Harbin Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.